×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Coronavirus | stem cell | research | biotechnology | umbilical cord

New Stem Cell Therapy for COVID-19 Patients Is Successful

polish lab worker in mast and gloves picking up a tray with pouches of umbilical cord blood
A laboratory worker prepares umbilical cord blood and cord, collected from hospitals, for storage at the headquarters of the Polish umbilical cord blood bank in Warsaw. (Wojtek Radwanski/Getty Images)

By    |   Tuesday, 05 May 2020 03:03 PM

Three critically ill COVID-19 patients at Baptist Hospital in Miami were the first in the U.S. to be successfully treated with stem cells.

The patients were suffering from acute respiratory distress syndrome, or ARDS, and doctors infused them intravenously with cells derived from the lining of umbilical cords.

These are called mesenchymal stem cells and within days after the infusion, the patients who needed 100% oxygen on ventilator support, saw their requirement slashed in half. This significant reduction was also accompanied by a drop in inflammatory markers, meaning that the harmful inflammation crippling the lungs was not only arrested but reversed, according to Baptist Health South Florida.

“The remarkable ability for these cells to mitigate inflammatory processes holds great promise for COVID-19 patients as well as for people with other illnesses,” said Dr. Guenther Koehne, deputy director and chief of blood and marrow transplant at Miami Cancer Institute, part of Baptist Health, and principal investigator of the study.

All three patients were critically ill and suffered from serious co-morbidities as well as other underlying conditions.

According to Technology Networks, stem cell therapy is proving to be efficient in treating severely ill COVID-19 patients in other parts of the world as well. Sun Yanrong, deputy head of the China National Center for Biotechnology Development said that stem cell treatment has already been used in more than 200 cases in the most affected area of China, the city of Wuhan.

“Our preliminary results show that therapy with these cells could be a game changer for COVID-19,” said Dr. Javier Perez-Fernandez, a pulmonologist and director of critical care at Baptist Hospital. “I’m very excited about this treatment because I really think it’s going to work. And if it works as we expect, it’s going to change dramatically the way we treat these patients.”

The stem cells are grown from umbilical cord tissue by California-based RESTEM, a biotechnology company that has a patent for the umbilical cord mesenchymal cells, according to the Miami Herald.

Researchers have been investigating the effect of those cells on autoimmune diseases for over a decade, to determine whether they are effective in reversing what’s known as a cytokine storm, where the immune system goes into overdrive attempting to fight a virus and winds up attacking its own cells instead.

The Baptist Health study is being reviewed for the Food and Drug Administration, which approved the clinical trial under an emergency approval.

© 2021 NewsmaxHealth. All rights reserved.


Health-News
Three critically ill COVID-19 patients at Baptist Hospital in Miami were the first in the U.S. to be successfully treated with stem cells. The patients were suffering from acute respiratory distress syndrome or ARDS, and doctors infused them intravenously with cells derived...
stem cell, research, biotechnology, umbilical cord
405
2020-03-05
Tuesday, 05 May 2020 03:03 PM
Newsmax Media, Inc.
Join the Newsmax Community
Register To Comment Login To Comment
Please review Community Guidelines before posting a comment.
 
Find Your Condition
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved